Curated News
By: NewsRamp Editorial Staff
November 17, 2026

AHA: CAC Test Not for Everyone, but a Key Decision Aid

TLDR

  • Gain an edge by using the American Heart Association's CAC test as a tiebreaker to refine statin decisions when cardiovascular risk is borderline or intermediate.
  • The CAC test is a 10-15 minute noninvasive CT scan that measures coronary calcium to produce a score, guiding cholesterol treatment when risk is uncertain.
  • The American Heart Association's guidance on CAC testing helps people make informed heart health decisions, potentially preventing heart attacks and strokes for longer, healthier lives.
  • A CAC score of zero is reassuring but not a lifetime all-clear, as noncalcified plaque and other risk factors like diabetes and smoking still matter.

Impact - Why it Matters

This news matters because it clarifies the appropriate use of CAC testing, helping patients and providers avoid unnecessary scans while ensuring those who could benefit most—those at borderline or intermediate risk—receive personalized care. By emphasizing shared decision-making and lifestyle changes as the foundation of prevention, the AHA empowers individuals to take control of their heart health and have informed conversations with their doctors. With cardiovascular disease remaining a leading cause of death, understanding when and how to use tools like CAC scoring can lead to more targeted, effective prevention and ultimately save lives.

Summary

The American Heart Association (AHA) is clarifying the role of the coronary artery calcium (CAC) test, a quick, noninvasive CT scan that detects calcium deposits in the coronary arteries—an early sign of atherosclerosis. In a recent release, the AHA emphasizes that CAC testing is not necessary for everyone and should be used selectively. The American Heart Association/American College of Cardiology dyslipidemia guideline supports CAC scoring as a decision aid for people at borderline (3% to less than 5%) or intermediate (5% to less than 10%) risk of cardiovascular disease when the decision to start or intensify cholesterol-lowering treatment, such as statins, is uncertain. The guideline encourages using the American Heart Association’s PREVENT™ equations as the starting point for risk estimation, with CAC as a tiebreaker when risk remains unclear.

Manesh R. Patel, M.D., FAHA, volunteer president of the American Heart Association, stresses that CAC is not a broad screening tool but a “tiebreaker test” for those at borderline or intermediate risk. The scan takes 10 to 15 minutes, uses low-dose radiation, and typically costs $100 to $400, often not covered by insurance. The AHA outlines four key points for consumers: first, have a conversation with a healthcare professional about overall risk and whether a CAC score would change management; second, the test detects existing plaque, with higher scores indicating greater risk; third, it is not an annual screening but a potential decision-making tool, with lifestyle modification as the first line of prevention, including the Life’s Essential 8™ metrics; and fourth, a zero score is reassuring but not a lifetime guarantee, as noncalcified plaque and other risk factors still matter. The AHA provides resources such as the coronary artery calcium testing (CAC test) from the American Heart Association and the Life's Essential 8™ My Life Check Calculator to help individuals assess their heart health and discuss with their healthcare team.

Source Statement

This curated news summary relied on content distributed by NewMediaWire. Read the original source here, AHA: CAC Test Not for Everyone, but a Key Decision Aid

Blockchain registration record for this content